Literature DB >> 17019435

Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome.

Mariana M Cajaiba1, Allen E Bale, Mayra Alvarez-Franco, Joseph McNamara, Miguel Reyes-Múgica.   

Abstract

BACKGROUND: A 5-year-old year girl with a medical history of mental retardation, physical abnormalities and a known interstitial deletion of chromosome 9q22-q32 presented with a palpable suprapubic mass. During ultrasound investigation, a left renal mass was also detected. The patient underwent surgical removal of both neoplasms, which were diagnosed as a rhabdomyosarcoma and a Wilms tumor. Seven years later, she presented with macroglossia and a benign mandibular cyst. INVESTIGATIONS: Physical examination, karyotyping, abdominal and pelvic ultrasound, brain CT scan, anatomic pathology analysis with immunohistochemistry, and typing of polymorphic markers in the patched (PTCH) gene region. DIAGNOSIS: Gorlin syndrome with synchronous rhabdomyosarcoma and Wilms tumor. MANAGEMENT: Left nephrectomy, excision of paravesical tumor, excision of mandibular cysts, chemotherapy, and radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019435     DOI: 10.1038/ncponc0608

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  15 in total

1.  9q22 Deletion--first familial case.

Authors:  Linda Siggberg; Maarit Peippo; Marjatta Sipponen; Taina Miikkulainen; Keiko Shimojima; Toshiyuki Yamamoto; Jaakko Ignatius; Sakari Knuutila
Journal:  Orphanet J Rare Dis       Date:  2011-06-22       Impact factor: 4.123

2.  Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.

Authors:  Bertrand Isidor; Franck Bourdeaut; Delfine Lafon; Ghislaine Plessis; Elodie Lacaze; Caroline Kannengiesser; Sylvie Rossignol; Olivier Pichon; Annaig Briand; Dominique Martin-Coignard; Maria Piccione; Albert David; Olivier Delattre; Cécile Jeanpierre; Nicolas Sévenet; Cédric Le Caignec
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

3.  Childhood cancer and developmental biology a crucial partnership.

Authors:  Sara Federico; Rachel Brennan; Michael A Dyer
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 4.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

5.  A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.

Authors:  Adepitan A Owosho; Shih-Chiang Huang; Sonja Chen; Shruti Kashikar; Cherry L Estilo; Suzanne L Wolden; Leonard H Wexler; Joseph M Huryn; Cristina R Antonescu
Journal:  Oral Oncol       Date:  2016-09-06       Impact factor: 5.337

6.  Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.

Authors:  Leanne de Kock; Ju-Yoon Yoon; Blaise A Clarke; William D Foulkes; Maria Apellaniz-Ruiz; Dylan Pelletier; W Glenn McCluggage; Colin J R Stewart; Brendan C Dickson; Marjan Rouzbahman
Journal:  Mod Pathol       Date:  2020-01-03       Impact factor: 7.842

7.  Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Authors:  Simone Hettmer; Natasha M Archer; Gino R Somers; Ana Novokmet; Amy J Wagers; Lisa Diller; Carlos Rodriguez-Galindo; Lisa A Teot; David Malkin
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

8.  Immunohistochemical analysis of Sonic hedgehog signalling in normal human urinary tract development.

Authors:  Dagan Jenkins; Paul J D Winyard; Adrian S Woolf
Journal:  J Anat       Date:  2007-09-11       Impact factor: 2.610

9.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

10.  Myogenic tumors in nevoid Basal cell carcinoma syndrome.

Authors:  Simone Hettmer; Lisa A Teot; Harry Kozakewich; Annette M Werger; Kimberly J Davies; Christopher D M Fletcher; Holcombe E Grier; Carlos Rodriguez-Galindo; Amy J Wagers
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.